India  

Covid vaccine recipients may not be able to pick & choose

IndiaTimes Tuesday, 12 January 2021 ()
Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they want to be inoculated with.
0
shares
ShareTweetSavePostSend
 
Video Credit: CBS 2 New York - Published
News video: Some Eligible New Yorkers Struggling To Book COVID Vaccine Appointments

Some Eligible New Yorkers Struggling To Book COVID Vaccine Appointments 02:20

New York State is following the new CDC guidelines, allowing more people to get the coronavirus vaccine, but Gov. Andrew Cuomo warns the state will not be able to keep up with demand; CBS2's Carolyn Gusoff reports.

You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

This dog arrived in elevator for a walk by a neighbor while the owner has COVID [Video]

This dog arrived in elevator for a walk by a neighbor while the owner has COVID

This woman unexpectedly became a dog walker for a stranger in her apartment building in Poland while the dog's owner is quarantining with COVID-19.

Credit: USA Today News (International)    Duration: 00:35Published
Coronavirus in numbers: UK death toll reaches 89,860 [Video]

Coronavirus in numbers: UK death toll reaches 89,860

Public Health England said a further 599 people had died within 28 days oftesting positive for Covid-19 in the UK as of Monday.

Credit: PA - Press Association STUDIO    Duration: 00:37Published

COVID-19: Two dead after receiving shot, govt says deaths not linked to vaccine

Since the beginning of the COVID-19 vaccination drive in India on January 16, 580 adverse events were observed and seven people were hospitalised.
DNA

England in Six Nations: Jason Ryles absent because of Covid-19 travel fears

Assistant coach Jason Ryles will not be with England for the Six Nations because of travel concerns but hopes to re-join the staff for the summer fixtures.
BBC Sport
580 adverse events reported post-COVID immunisation: Health Ministry [Video]

580 adverse events reported post-COVID immunisation: Health Ministry

Additional Secretary of Health Ministry Manohar Agnani informed that a total of 580 adverse events were reported post-vaccination drive. He said, "A cumulative of 580 Adverse Events Following Immunisation (AEFIs) has been reported. Of which 7 have been hospitalised."

Credit: ANI    Duration: 01:03Published

AZD1222 AZD1222 Vaccine against COVID-19

India may get four more COVID-19 vaccines soon, SII says work in progress

According to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield.
DNA
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published

University of Oxford University of Oxford Collegiate research university in Oxford, England

Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

Credit: ANI    Duration: 02:39Published

Serum Institute expects WHO emergency approval for AstraZeneca shot soon

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for..
IndiaTimes
COVID vaccine: From factory to arm, the logistics of rolling out the Oxford-AstraZeneca jab [Video]

COVID vaccine: From factory to arm, the logistics of rolling out the Oxford-AstraZeneca jab

The pace of the UK's vaccine rollout was ramped up this week with the opening of seven new mass vaccination centres

Credit: Euronews English    Duration: 02:33Published

AstraZeneca 'on track' to deliver two million doses a week - as it calls for priority access

AstraZeneca says it expects to release two million doses of the Oxford vaccine every week by mid-February - and has asked for its workers to get priority access..
Sky News
Study: Ireland saw highest global coronavirus infection rate [Video]

Study: Ireland saw highest global coronavirus infection rate

New research from Oxford University shows Ireland had the highest coronavirus infection rate globally in the seven days leading up to January 10, 2021. CNN’s Nic Robertson reports.

Credit: Bleacher Report AOL    Duration: 01:58Published

AstraZeneca British-Swedish pharmaceutical company

Vaccine manufacturing is lumpy, UK says [Video]

Vaccine manufacturing is lumpy, UK says

Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said on Monday. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:24Published
Sao Paulo nurse first to get CoronaVac shot in Brazil [Video]

Sao Paulo nurse first to get CoronaVac shot in Brazil

Monica Calazans, a 54-year-old nurse in Sao Paulo, became on Sunday the first person to be inoculated in Brazil, receiving the Chinese vaccine known as CoronaVac after Brazilian health regulator Anvisa approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca.

Credit: Reuters Studio    Duration: 00:54Published
Easing of lockdown restrictions not before March, says Zahawi [Video]

Easing of lockdown restrictions not before March, says Zahawi

Vaccines minister Nadhim Zahawi has suggested that a gradual easing oflockdown restrictions will not begin before early March. He told BBCBreakfast: “If we take the mid-February target, two weeks after that you getyour protection, pretty much, for the Pfizer/BioNTech, three weeks for theOxford/AstraZeneca, you are protected. “One of the things we don’t know yet,and the deputy chief medical officer Jonathan Van-Tam is on record as saying‘look give me a couple of months and I’ll tell you’, is the impact of thevaccine on transmission rates ie on infecting people. “So there are a numberof caveats that stand in the way of us reopening the economy. “It will begradually, it will be probably through the tiered system but you’re looking atthat sort of period, two to three weeks after the middle of February, afterwe’ve protected the top four cohorts.”

Credit: PA - Press Association STUDIO    Duration: 00:53Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

BBV152 BBV152 Vaccine against COVID-19


Related videos from verified sources

Can COVID-19 Vaccine Recipients Still Transmit the Virus? [Video]

Can COVID-19 Vaccine Recipients Still Transmit the Virus?

Can COVID-19 Vaccine Recipients Still Transmit the Virus?

Credit: Cerise Media English     Duration: 01:09Published
Watch: India's first vaccine recipients get shots after PM Modi's speech [Video]

Watch: India's first vaccine recipients get shots after PM Modi's speech

After a wait of almost a year, the end to the Covid-19 pandemic seems to be in sight. India launched its vaccination drive against the disease on January 16, 2021 after Prime Minister Narendra Modi..

Credit: HT Digital Content     Duration: 02:10Published
Concerns about equal access to COVID-19 vaccines [Video]

Concerns about equal access to COVID-19 vaccines

If San Diego County is able to get enough COVID-19 doses, there's a concern among some seniors about equal access to signing up for an appointment.

Credit: ABC 10 News | San Diego     Duration: 02:21Published

Related news from verified sources

Bharat Biotech clarifies on COVAXIN usage

Company releases fact sheet detailing possible adverse events and those who are eligible for the vaccine
Hindu Also reported by •IndiaTimesDNA

Bengal CM ‘science’ poser to Centre on Covaxin and Covishield

Bengal CM Mamata Banerjee on Monday asked whether “adequate scientific confirmation was available in support of” the vaccines Covishield and Covaxin, which...
IndiaTimes Also reported by •Hindu

Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK Paul

Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects...
IndiaTimes Also reported by •HinduDNA